Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim Gives $65M to JGU Mainz for Life Sciences

NEW YORK (GenomeWeb News) – The Johannes Gutenberg University Mainz will receive €50 million ($65.4 million) over the next 10 years from the Boehringer Ingelheim Foundation to fund its life sciences activities, the university said on Friday.

The funding will go toward efforts to consolidate JGU's biology program around its Institute of Molecular Biology.

The IMB was established with €100 million in funding from the foundation in 2009, and now JGU said plans for this institute to serve as the basis of its biology activities and faculty.

The German university also said it has plans to construct a new biology research building using additional funding from the state government, JGU said, and to recruit new life sciences faculty members, with the specific aim of supporting young researchers.

IMB's current research efforts include studies involving developmental biology, epigenetics, DNA repair, and similar biomedical areas.

The institute's research capabilities include core facilities that provide services for next-generation sequencing, microarray analysis, bioinformatics, high-end microscopy, and cytometry.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more